High incidence of pulmonary toxicity of weekly docetaxel and gemcitabine in patients with non-small cell lung cancer: results of a dose-finding study-Reference-Cited by-同舟云学术

High incidence of pulmonary toxicity of weekly docetaxel and gemcitabine in patients with non-small cell lung cancer: results of a dose-finding study

Published:2004-06 Issue:3 Volume:44 Page:363-368
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Kouroussis Charalambos,Mavroudis Dimitris,Kakolyris Stylianos,Voloudaki Argyro,Kalbakis Konstantinos,Souglakos John,Agelaki Sophia,Malas Konstantinos,Bozionelou Vassiliki,Georgoulias Vassilis

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference28 articles.

1. Are platinum compounds mandatory in the treatment of metastatic non-small cell lung cancer?;Ruckdeschel;Eur. J. Cancer,1999

2. Novel chemotherapeutic agents in the treatment of non-small cell lung cancer;Lilenbaum;J. Clin. Oncol.,1993

3. Platinum-based and non-platinum based chemotherapy in advanced non-small cell lung cancer: a randomised multicenter trial;Georgoulias;Lancet,2001

4. Combination chemotherapy with paclitaxel plus carboplatin versus paclitaxel plus gemcitabine in inoperable non-small cell lung cancer: a phase III randomized study. Preliminary results. Hellenic Cooperative Oncology Group;Kosmidis;Semin. Oncol.,2000

5. Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naı̈ve patients with advanced non-small cell lung cancer;Fossella;J. Clin. Oncol.,1997

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics and outcomes of gemcitabine-associated pulmonary hypertension;ERJ Open Research;2024-05

2. Does shortening the duration of radiotherapy treatment in breast cancer increase the risk of radiation pneumonia: A retrospective study;Medicine;2023-03-24

3. Systematic risk analysis of radiation pneumonitis in breast cancer: role of cotreatment with chemo-, endocrine, and targeted therapy;Strahlentherapie und Onkologie;2022-12-14

4. Solute Carrier Nucleoside Transporters in Hematopoiesis and Hematological Drug Toxicities: A Perspective;Cancers;2022-06-25

5. A Review of Treatment-Induced Pulmonary Toxicity in Breast Cancer;Clinical Breast Cancer;2022-01